Michael B. Fowler

Active 1965–2024

47
Papers
23,362
Citations
45
h-index
47
i10-index

Citations

Citations per year for Michael B. Fowler1966: 1 citations1967: 1 citations1968: 2 citations1969: 1 citations1970: 2 citations1971: 1 citations1972: 2 citations1976: 1 citations1981: 1 citations1982: 1 citations1987: 4 citations1988: 13 citations1989: 21 citations1990: 22 citations1991: 17 citations1992: 20 citations1993: 27 citations1994: 20 citations1995: 43 citations1996: 63 citations1997: 113 citations1998: 142 citations1999: 197 citations2000: 177 citations2001: 208 citations2002: 231 citations2003: 265 citations2004: 255 citations2005: 236 citations2006: 201 citations2007: 178 citations2008: 134 citations2009: 151 citations2010: 135 citations2011: 113 citations2012: 128 citations2013: 115 citations2014: 77 citations2015: 82 citations2016: 81 citations2017: 92 citations2018: 65 citations2019: 213 citations2020: 225 citations2021: 234 citations2022: 183 citations2023: 122 citations2024: 177 citations2025: 80 citations2026: 3 citations1973–1975: no citations, so these years are not shown1977–1980: no citations, so these years are not shown1983–1986: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 1,784 citing papers, 31.3% of this breakdownUnited Kingdom: 475 citing papers, 8.3% of this breakdownGermany: 368 citing papers, 6.4% of this breakdownItaly: 344 citing papers, 6% of this breakdownCanada: 277 citing papers, 4.9% of this breakdownJapan: 207 citing papers, 3.6% of this breakdownFrance: 193 citing papers, 3.4% of this breakdownNetherlands: 191 citing papers, 3.3% of this breakdownAustralia: 175 citing papers, 3.1% of this breakdownSweden: 154 citing papers, 2.7% of this breakdownChina: 143 citing papers, 2.5% of this breakdownSpain: 113 citing papers, 2% of this breakdown
0%31.3%Other 22.5%

Fields

  • Medicine84.4%
  • Biochemistry, Genetics and Molecular Biology9.9%
  • Engineering1.5%
  • Neuroscience0.7%
  • Health Professions0.6%
  • Immunology and Microbiology0.6%
  • Other2.3%

Topics

  • Heart Failure Treatment and Management13.6%
  • Cardiovascular Function and Risk Factors8.8%
  • Cardiac pacing and defibrillation studies4.1%
  • Cardiac electrophysiology and arrhythmias3.7%
  • Cardiovascular and exercise physiology2.3%
  • Cardiac Fibrosis and Remodeling2.3%
  • Other65.2%

Coauthors

All papers

Open in search
  1. The Effect of Carvedilol on Morbidity and Mortality in Patients with Chronic Heart Failure

    Authors: , , , , , , - New England Journal of Medicine 1996 cited by 4,672

  2. Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure

    Authors: , , , , , , , , , , , , - Circulation 2002 cited by 1,346

  3. Effect of Carvedilol on Survival in Severe Chronic Heart Failure

    Authors: , , , , , , , , , , , , , - New England Journal of Medicine 2001 cited by 3,096

  4. Carvedilol Produces Dose-Related Improvements in Left Ventricular Function and Survival in Subjects With Chronic Heart Failure

    Authors: , , , , , , , , , , , - Circulation 1996 cited by 1,306

  5. Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.

    Authors: , , , , , , , , , - Circulation Research 1986 cited by 1,320

  6. Insulin-Resistant Cardiomyopathy

    Authors: , - Journal of the American College of Cardiology 2008 cited by 355

  7. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy

    Authors: , , , , , , , , , - The Lancet 1993 cited by 1,239

  8. Influence of pretreatment systolic blood pressure on the effect of carvedilol in patients with severe chronic heart failure

    Authors: , , , , , , , , , , , - Journal of the American College of Cardiology 2004 cited by 149

  9. Expression of Inducible Nitric Oxide Synthase in Human Heart Failure

    Authors: , , , , , , , , , , , , - Circulation 1996 cited by 494

  10. Acute Pyogenic Meningitis Probably Due to Acanthamoeba sp.: a Preliminary Report

    Authors: , - BMJ 1965 cited by 350

  11. A Changing Landscape of Mortality for Systemic Light Chain Amyloidosis

    Authors: , , , , , , , , , , - JACC Heart Failure 2019 cited by 58

  12. Novel Role for the Potent Endogenous Inotrope Apelin in Human Cardiac Dysfunction

    Authors: , , , , , , , , , , , , , , , , , , - Circulation 2003 cited by 348

  13. Safety and efficacy of carvedilol in severe heart failure

    Authors: , , , , , , , , , , , , - Journal of Cardiac Failure 1997 cited by 221

  14. Carvedilol Inhibits Clinical Progression in Patients With Mild Symptoms of Heart Failure

    Authors: , , , , , , , , , , , , , - Circulation 1996 cited by 635

  15. Influence of preoperative pulmonary artery pressure on mortality after heart transplantation: Testing of potential reversibility of pulmonary hypertension with nitroprusside is useful in defining a high risk group

    Authors: , - Journal of the American College of Cardiology 1992 cited by 417

  16. Effects of Initiating Carvedilol in Patients With Severe Chronic Heart Failure

    Authors: , , , , , , , , , - JAMA 2003 cited by 307

  17. Short‐term outcomes of en bloc combined heart and liver transplantation in the failing Fontan

    Authors: , , , , , , , , , - Clinical Transplantation 2019 cited by 67

  18. Prognostic Impact of Plasma N-Terminal Pro–Brain Natriuretic Peptide in Severe Chronic Congestive Heart Failure

    Authors: , , , , , , , , , , , , - Circulation 2004 cited by 302

  19. Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure

    Authors: , , , , , , , - Journal of the American College of Cardiology 1999 cited by 240

  20. Serial Cardiac FDG-PET for the Diagnosis and Therapeutic Guidance of Patients With Cardiac Sarcoidosis

    Authors: , , , , , - Journal of Cardiac Failure 2019 cited by 57

  21. Guidelines for the Evaluation and Management of Heart Failure

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Circulation 1995 cited by 668

  22. AT1and AT2Angiotensin Receptor Gene Expression in Human Heart Failure

    Authors: , , , , , , - Circulation 1997 cited by 185

  23. Insulin resistance in idiopathic dilated cardiomyopathy

    Authors: , , , , , - Journal of the American College of Cardiology 2004 cited by 109

  24. The use of exoskeleton robotic training on lower extremity function in spinal cord injuries: A systematic review

    Authors: , , , , , , , - Journal of Orthopaedics 2024 cited by 16